![Jason Hoitt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Hoitt
Företagsledare/Principal på
STOKE THERAPEUTICS, INC.
Förmögenhet: 336 231 $ per 2026-06-30
Profil
Jason Hoitt currently works at Stoke Therapeutics, Inc., as Chief Patient Officer from 2025.
Mr. Hoitt also formerly worked at Sarepta Therapeutics, Inc., as Head-US Sales from 2013 to 2017, Insmed, Inc., as Vice President & Head-US Sales, Dova Pharmaceuticals, Inc., as Chief Commercial Officer from 2018 to 2019, and Provention Bio, Inc., as Chief Commercial Officer from 2020 to 2023.
Mr. Hoitt received his undergraduate degree in 1999 from College of the Holy Cross (Massachusetts).
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
STOKE THERAPEUTICS, INC. 0,02 % | 2026-03-31 | 10 276 ( 0,02 % ) | 336 231 $ | 2026-06-30 |
Aktiva positioner av Jason Hoitt
| Företag | Position | Start |
|---|---|---|
| STOKE THERAPEUTICS, INC. | Företagsledare/Principal | 2024-04-15 |
Tidigare kända positioner av Jason Hoitt
| Företag | Position | Slut |
|---|---|---|
| PROVENTION BIO, INC. | Företagsledare/Principal | 2023-06-01 |
| DOVA PHARMACEUTICALS, INC. | Företagsledare/Principal | 2019-11-12 |
| INSMED INCORPORATED | Försäljning & Marknadsföring | - |
| SAREPTA THERAPEUTICS, INC. | Försäljning & Marknadsföring | 2017-05-01 |
Jason Hoitts utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
65
Första gradens relationer
6
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Insmed, Inc.
 Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
College of the Holy Cross (Massachusetts)
 College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs with disorder of low blood platelet count | Health Technology |
Stoke Therapeutics, Inc.
 Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases | Health Technology |
Provention Bio, Inc.
 Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company that engages in intercepting and preventing immune-mediated diseases including type 1 diabetic activities | Health Technology |
